← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2020Last known activity
Oct 2, 2024
Timeline
2010s
- Jun 1, 2019
Alto Neuroscience— Founded
Drugs by trial phase (8 distinct, 11 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06656416OfficialPhase 2Oct 2, 2024
- NCT06656416Lead sponsorPhase 2Oct 2, 2024
- NCT06502964Lead sponsorPhase 2Jul 31, 2024
- NCT06391593Lead sponsorPhase 2Mar 25, 2024
- NCT05922878Lead sponsorPhase 2Jun 8, 2023
- NCT05922878Study directorPhase 2Jun 8, 2023
- NCT05712187Study directorPhase 2Jan 10, 2023
- NCT05712187Lead sponsorPhase 2Jan 10, 2023
- NCT05419869Lead sponsorPhase 2Jun 1, 2022
- NCT05157945Lead sponsorPhase 2Dec 31, 2021
- NCT05118750Lead sponsorPhase 2Nov 30, 2021
- NCT05117632Lead sponsorPhase 2Nov 30, 2021
- NCT04388189Lead sponsorPhase 4Jun 1, 2020
- NCT04388202Lead sponsorPhase 4Jun 1, 2020
- NCT04388202Study directorPhase 4Jun 1, 2020
Details
- Founded
- Los Altos, CA, US Jun 1, 2019
- Last known activity
- Oct 2, 2024
Notes
diagnostics